GENEVA, Aug. 14 -- TR1X, INC. filed a patent application (US2026/013978) for “POLYDONOR CD4+ T CELLS EXPRESSING IL-10 IN COMBINATION WITH HEMATOPOIETIC STEM CELLS FOR USE IN A TREATMENT OF HEMATOLOGICAL MALIGNANCIES”. With publication no. WO/2026/169796, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 40/11
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....